Shimontini Mitra, MBCHB

Shimontini Mitra practices at Fenway Health Radiology Department in Boston, Massachusetts.

Shimontini Mitra's NPI, 1235576836, was assigned on May 23, 2013. Shimontini Mitra holds Massachusetts license 273856.

Shimontini Mitra's primary practice is Fenway Health Radiology Department, at 1340 Boylston St., Boston, MA 02215. The practice phone is (857) 313-6563.

Shimontini Mitra's primary practice is Fenway Health Radiology Department in Boston, Massachusetts. Shimontini Mitra is also affiliated with Beth Israel Deaconess Medical Center. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Shimontini Mitra to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shimontini Mitra practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Shimontini Mitra's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Shimontini Mitra is licensed in Massachusetts.

CMS data shows 1,470 Medicare services from Shimontini Mitra across 22 procedure codes in 2024, for 320 Medicare patients. Medicare paid $65,528 for them.

CMS counts 320 Medicare patients who saw Shimontini Mitra in 2024. The largest group is 75 to 84, with 123 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Shimontini Mitra's median patient age at 72, with 49% women.

In 2024, Shimontini Mitra wrote 368 Medicare Part D claims for 100 patients. 80% of them were for generic drugs. CMS names the drug for 304 of them, across 9 drugs with 11 or more claims each, at $41,403 in total drug cost. In 2023, CMS named 252 claims across 11 drugs.

Shimontini Mitra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Shimontini Mitra as offering telehealth.

Dmand AI links 3 papers to Shimontini Mitra, published from 2014 to 2023. Shimontini Mitra's most frequent co-authors are Richard Babicz, MD and Pui Wen Cheung, MD.

CMS Open Payments shows 3 general payments to Shimontini Mitra from 1 drug or device company in 2025. Education make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $5.